Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
Andrea Castillo, BS
CONTACT
Lei Gao, MD
CONTACT
NCT Number: NCT06375265
The Sleep Optimization for Brain Health Outcomes in Older Surgical Patients (SLEEP-BOOST) is a pilot randomized, controlled, singled-blinded (participant) trial in major orthopedic joint surgery patients that will build on a previously clinically tested cognitive behavioral therapy for insomnia (CBT-I) mobile application paired with a wearable device (wrist actigraphy).
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Andrea Castillo, BS
CONTACT
Lei Gao, MD
CONTACT
CBT-I is the frontline treatment for insomnia but is not considered for preoperative care of older surgical patients with insomnia who are at risk of perioperative neurocognitive disorders associated with sleep/circadian dysfunction. We propose to determine if digital CBT-I (dCBT-I) is feasible for treating older surgical patients with insomnia symptoms and to examine the effects of dCBT-I on sleep, cognitive trajectory, mood, pain, activity, and function after surgery. The Sleep Optimization for Brain Health Outcomes in Older Surgical Patients (SLEEP-BOOST) is a pilot randomized, controlled, singled-blinded (participant) trial in major orthopedic joint surgery patients that will build on a previously clinically tested CBT-I mobile application paired with a wearable device (wrist actigraphy).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Preoperative hybrid intervention (in-person or via phone/video) over 4 weeks, and at 2 weeks, and 1 month after surgery using content from the CBT-I Coach app from Veteran Affairs.
Sleep Health Education materials provided
Time frame: After dCBT-I intervention during Review session ~1 day to 3 weeks before surgery.
A Patient Adherence Form developed by the Veterans Affairs CBT-I Training Program will be used to assess adherence to the protocol. A mean adherence score across six domains showing good psychometric properties will be derived (0-24; higher represents more adherent)
Time frame: Throughout the study 3-4 weeks before surgery, and 2 weeks, 1 month and 3 months after surgery.
The number of days of completed sleep diaries and actigraphy will be recorded.
Time frame: After dCBT-I intervention during Review session ~1 day to 3 weeks before surgery.
The amount of time spent on CBT-I homework will be recorded.
Time frame: At screening, baseline, every session of the dCBT-I/control 3-week intervention period, 2 weeks, 1- and 3-months after surgery
The Insomnia Severity Index (ISI) questionnaire will be used to determine the quality of sleep for patients (0 to 28; higher represents more severe insomnia symptoms)
Time frame: At baseline, every session of the dCBT-I/control 3-week intervention period, 2 weeks, 1- and 3-months after surgery
The Pittsburgh Sleep Quality Index (PSQI) questionnaire will be used to assess subjective sleep quality in patients (range 0 to 21; higher scores indicate worse sleep quality).
Time frame: After dCBT-I intervention during Review session ~1 day to 1 week before surgery.
A 16-item digital intervention utility questionnaire will be used to assess patient usage of the app (0-64; higher represents more perceived utility)
Time frame: After dCBT-I intervention during Review session ~1 days to 1 week before surgery.
A 9-item survey will be used to assess which elements of the app were most helpful and the likelihood the patient would recommend it to family/friends.
Time frame: At baseline and 2 weeks, 1- and 3-months after surgery
Telephonic Montreal Cognitive Assessment (tMoCA) test to assess cognition
Time frame: At baseline, end of the dCBTI/control intervention pre-surgery and 2 weeks, 1- and 3-months after surgery
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain will measure functional pain severity
Time frame: At baseline and 1- and 3-months after surgery
The Geriatric Depression Scale-15 will be used to assess the mood of the patients (0-15; higher represents more severe mood/depression symptoms). Generalize Anxiety Disorder 7 (GAD-7; 0-21; higher represents more anxiety symptoms)
Time frame: From postoperative day 1 to postoperative day 3
The Confusion Assessment Method (3D-CAM) will be used to monitor signs of delirium in patients.
Time frame: From postoperative day 1 to postoperative day 3
The Confusion Assessment Method (CAM)-Severity assessment will be used to monitor signs of delirium severity in patients.
Time frame: At 1-months after surgery
Using cognitive change from baseline (1 standard deviation from the mean).
Time frame: At 3-months after surgery
Using cognitive change from baseline (1 standard deviation from the mean).
Time frame: At baseline, immediately after the intervention, and 2 weeks, 1- and 3-months after surgery
Motor activity will be recorded on wrist actigraphy watches to derive amplitude, acrophase, interdaily stability, intradaily variability, most active 10h (M10), least active 5h (L5), relative amplitude (RA), fractal motor activity regulation (FMAR).
Time frame: Before baseline session, on surgery day, and once on post-operative days 1-3
Collection of blood samples from participant
Contact information is provided by the study sponsor or research team.
Andrea Castillo, BS
CONTACT
Mili Jimenez Gallardo
CONTACT
Massachusetts General Hospital
Other
A Pilot Study of Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients (SLEEP-BOOST)
Acronym: SLEEP-BOOST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04092894
Confusion, Delirium
Boston, Massachusetts, United States
View Trial DetailsNCT07735390
Dyssomnias, Insomnia
Tainan, Taiwan
View Trial DetailsNCT07299240
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT07191119
Acute Lymphoblastic Leukemia (ALL), Dyssomnias
Memphis, Tennessee, United States
View Trial Details